**----- Start of picture text -----**
The Faccenda Foundation 1124009
Receipts and payments accounts CC16a
For the period 01/04/2022 31/03/2023
To
from
Section A Receipts and payments
Unrestricted Restricted Endowment
Total funds Last year
funds funds funds
to the nearest
to the nearest £ to the nearest £ to the nearest £ to the nearest £
£
A1 Receipts
Donations 45,000 - - 45,000 50,000
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total (Gross income for
45,000 - - 45,000 50,000
AR)
A2 Asset and investment sales,
(see table).
- - - -
- - - - -
Sub total - - - - -
Total receipts 45,000 - - 45,000 50,000
A3 Payments
Donations paid 46,000 - - 46,000 46,250
Bank charges 1 - - 1 5
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total [ 46,001 ] - - 46,001 46,255
A4 Asset and investment
purchases, (see table)
- - - -
- - - -
Sub total [ - ] - - - -
Total payments 46,001 - - 46,001 46,255
Net of receipts/(payments) - 1,001 - - - 1,001 3,745
A5 Transfers between funds - - - - -
A6 Cash funds last year end 8,639 - - 8,639 4,894
Cash funds this year end 7,638 - - 7,638 8,639
**----- End of picture text -----**
CCXX R1 accounts (SS)
24/01/2025
1
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
Bank current account
**Details**
**Details**
**Details**
Signature|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**7,638**
**-**
**-**
**-**
**-**
**-**
**7,638**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
IAN FACCENDA|**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**|
|---|---|---|---|
||||**-**|
||||OK|
||||**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**When due**
**(optional)**
Date of
approval
27/01/2025|
CCXX R2 accounts (SS)
24/01/2025
2
- �
� �
- !"# #$! # % &!! $'! (%)*&%(%+&(,# ( - % #*'! . (! %) )/01(!+ 232/4
- � (++'"% # (5 6 %$! $(! )&%(++'!)(%+ 7& 8 (!& & #9+ 2300(%) :;<<=>?@A?BD?EFGH=I@A?BJKLMDIA@AGNOP@D@GQG?@=RFG<=QQG?EGESID<@AJTA<=R[IGTD?E\]FP^_`ab\DNDQG?EGER=ID<<=>?@A?BHGIA=EN +'-- %+&%U� �*!'-�0c(%"(!.�230de4� � � � ~~� � � � � � � � � � � � � � �� � � � � �� � � � � � � � C C C C C C C C C C C~~
- ~~� � � �� � � � � � � �� � C C C C C C C C C C C C � �� � �~~
- �� fghijklhm�nop�nijklkjkhm� �'6q + &5 #�'*� �+ (!& .�(! � '�-(r �U!(% #�(%)�)'%( &'%#�*'!� �6 % *& �'*�(%.� + (!& (6, �&%# & " &'%#�'!�*'!�#"+ �+ (!& (6, �$"!$'# #�&%+,")&%U�7 ,*(! s� )"+( &'%s� �(! #s� !& (U s�#$'! �(%)�! ,&U&'%s�(#� � !"# #�# (,,�) !-&% 4�� � !"# #� (5 �$(&)�)" �! U(!)� '�U"&)(%+ �6.� �8 (!& .�8'--&##&'%�&%�) +&)&%U�7 ( � (+ &5& & #� �+ (!& .�# '",)�"%) ! (r �*'!� �$"!$'# #�'*� �$"6,&+�6 % *& 4�� � itkhlhuhojm�nop�vhwxywunoih�� �+ (!& .� (#�-() �(� ' (,�'*�2�)'%( &'%#�)"!&%U�@MGCKGDICzMAIA?BC@MGCKGDICD?EC@MGCN@GGNCHTD?C@=C<=?@A?>GC@=CQDGCNAQATDICE=?D@A=?NC@=CR>TRATC@MGC?::>@;<:AB;DAA?::>K;� QRSTUSQTQV
- � LLLLLLLLLLK;� "�'�1�- � MN�� � OD?:FPLLLLLLLL� �
- %"& ' "& " ()*+ " ,-./ '!, �
- 234567894:; <4==;>?4<@A>?476@> C[D7] E45=3FGFC H B FKGGL � I1BJ
- OF ~~� �~~
- ����������� !"#$######################## ~~� �~~ # ~~# �~~ P5;:;:Q;57@6>=RA?;73;S4T;>A:Q;5D@U4??676@>4RD3;;7DV
-
��
�
0 ~~�~~ X5;S@577@73;75AD7;;D@>:8;Y4:6>476@>@U73;4==@A>7D@U73;4Q@Z; ~~� �~~
-
�1 ~~�~~ � [\]^_`acd`\ef^gh`ijkl^`\eae]^emnenCoGCoFGFCp ~~�~~
- ��1 �
�B
~~�~~ qD73; ~~�~~ =345678 ~~�~~ 75AD7;;D ~~�~~ @U73;r5AD7s8@A45;5;DS@>D6QR; ~~� �~~ U@573;S5;S45476@> ~~� � � �~~ @U73;4==@A>7D6>4==@5?4>=;t67373;5;uA65;:;>7D ~~�� � ���~~ @U ~~��~~ 73;2345676;D ~~� �~~ q=7 ~~� �~~ vwxxcd`\ey[`ijp
- M
���N
~~� �~~ z^e{l^`_m^eh{e[`lk|ae}]|_m]`_lmlk`\ef^gh`~h][[lgm`h[]^^_enlg` A>?;5D;=76@>K@U73;FGq=74>?6>=45586>T@A7:8;Y4:6>476@>sX
- ~~� � � � � � � � � � � � � � �~~ 34Z;U@RR@t;?73;4SSR6=4QR;65;=76@>DT6Z;>Q873;23456782@::6DD6@>
- ~~� b b b b b b b �~~ A>?;5D;=76@>KPVPQV@U73;q=7p
- ~~��~~
-
W
� ~~�~~ X34Z; ~~� �~~ =@:SR;7;? ~~�~~ :8;Y4:6>476@>p ~~� � � �~~ X=@>U65: ~~� �~~ 7347>@:47;564R ~~� �~~ :477;5D ~~�~~ 34Z; ~~�~~ �1�
~~�~~ =@:; ~~� �~~ 7@:8477;>76@> ~~��~~ 6>=@>>;=76@> ~~� �~~ t673 ~~�~~ 73;;Y4:6>476@> ~~� �~~ t36=3 ~~�~~ T6Z;D ~~�~~ :; ~~�~~ =4AD; ~~b~~ 7@Q;R6;Z; ~~b ��~~ 73476>s4>8:47;564R5;DS;=7 ~~�~~ 4==@A>76>T5;=@5?Dt;5;>@7;S76>4==@5?4>=;t673D;=76@>CG@U ~~b~~ 73; ~~bb~~ q=7@5 ~~b b b b b b b b b b�~~ �73;4==@A>7D� �?@� >@7� 4==@5?� ��t673�73;�4==@A>76>T� �5;=@5?D� �� � � � � � � � � � �
- X34Z;�>@=@>=;5>D� 4>?�34Z;� =@:;� 4=5@DD>@@73;5:477;5D6>=@>>;=76@> t67373;;Y4:6>476@>7@t36=3477;>76@>D3@AR?Q;?54t>6>@5?;57@;>4QR;4 � � � � ��� � � � � � �
- S5@S;5A>?;5D74>?6>T@U73;4==@A>7D7@Q;5;4=3;?p
-
� � � � �� � � � � � � �
�
� � � � � � � � �
FoGoFGF
- MN
� � � � � �� � � � � � � � ��
- � � � � � � � � � �
-
� ;5:6@>;� � 8:;5D367R;876:SD@>6:67;? � � � � � � � � � � �� �
- q2q� � � � � � � � �� � � ��
- ~~� �~~ � � � � � � � � ~~� �~~
- ~~�~~
-
;>5@D;@AD;s6T37@t>@4? ~~�~~
- ~~��~~ 4>QA58
- ~~� � �� � � �~~ L
- ~~� �~~
-
W
� 1
W ~~� �~~
- W1IJ� � B ~~�~~ I1�BJ ~~� � � � � � � � � � � � �~~
- 9
4 �
- 56
�7
�
8�9
:�8 ~~��~~ :;�
<�7:�7
� =:<
�>7
�� �
� �